Status:
NOT_YET_RECRUITING
Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery
Lead Sponsor:
Ciusss de L'Est de l'Île de Montréal
Collaborating Sponsors:
Institut de Cardiologie de Montréal
Conditions:
Gastric Retention
Eligibility:
All Genders
18+ years
Brief Summary
Glucagon-like peptide-1 agonists (GLP-1RA) are a family of medications used for diabetes and weight loss. One of their effect is to slow down stomach emptying. The goal of this study is to evaluate th...
Detailed Description
Background: Glucagon-like peptide-1 receptor agonists (GLP-1RA) are glucose-lowering drugs that act through three mechanisms: stimulation of insulin secretion, inhibition of glucagon secretion and dec...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) class 1-4 patients
- Age ≥ 18 years old
- Fasted state (2 hours for clear liquids, 6 hours for solids)
- Elective surgery
- Last dose of once-weekly semaglutide or dulaglutide 7 days or more before surgery (for GLP-1RA group)
Exclusion
- Last dose of GLP-1RA less than 7 days before surgery
- Inability to lay on the right-side for ultrasound
- Pregnancy
- History of gastric surgery or large hiatal hernia
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT06500143
Start Date
September 1 2024
End Date
March 1 2025
Last Update
July 16 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.